Chronic pancreatitis is the inflammation of the pancreas, the organ that produces digestive enzymes and insulin. The continued inflammation leads to permanent damage and scarring of the pancreas. This scarring causes digestive problems and eventually leads to diabetes.

MCC’s investment supports the continued development of RMS’s patented technology and novel approach to develop a revolutionary protocol to grow healthy and resilient pancreatic cells to improve the lives of people with all types of diabetes.